Skip to main content
CHRS
NASDAQ Life Sciences

Coherus Q3 Revenue Misses at $14.3M, Net Loss Widens to $39.3M

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.77
Mkt Cap
$126.32M
52W Low
$0.732
52W High
$2.616
52W Position info
5.2% above low
Off High info
71% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

CHRS is trading near its 52-week low of $0.732 (5.2% above the low).

Summary

Coherus reported Q3 revenue of $14.274 million, well short of the $16 million IBES estimate — a roughly 11% miss. The bottom line was ugly: net loss of $39.334 million, operating loss of $33.649 million, and adjusted net loss of $31.205 million. That revenue figure is barely above the $13.6 million LOQTORZI run rate disclosed in the Q2 10-Q, so the top line is essentially flat while losses stay heavy. With the stock at $0.77 and a market cap near $126 million, the company is leaning on its $50M ATM and the ongoing biosimilar asset sale to fund operations, and it has announced a strategic prioritization plan that lowers the LOQTORZI revenue needed for core burn to $25M-$30M. The interim tagmokitug data from late October (75% confirmed response rate in untreated esophageal cancer) remains the pipeline story, but this quarter shows no financial cushion from it yet.

At the time of this announcement, CHRS was trading at $0.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $126.3M. The 52-week trading range was $0.73 to $2.62. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CHRS - Latest Insights

CHRS
Nov 09, 2026, 4:59 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.8008
Real-time Price: $0.8215 info
Change: +$0.0207 (+3%) info
Market Cap: $126.32M info
CHRS
Nov 09, 2026, 4:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7976
Real-time Price: $0.8215 info
Change: +$0.0239 (+3%) info
Market Cap: $126.32M info
CHRS
Oct 29, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $0.8215 info
Change: -$0.2285 (-22%) info
Market Cap: $126.32M info
CHRS
Sep 23, 2026, 1:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.25
Real-time Price: $0.8215 info
Change: -$0.4235 (-34%) info
Market Cap: $126.32M info
CHRS
Aug 17, 2026, 5:36 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $0.8215 info
Change: -$0.4085 (-33%) info
Market Cap: $126.32M info